Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed AstraZeneca’s (AZN) IMFINZI, administered ...

Riskified Ltd. , a leader in ecommerce fraud and risk intelligence, today announced it will release its fourth quarter and full-year 2024 financial results before the market opens on March 5, 2025. On ...

Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (OTC:ALPMF) (OTC:ALPMY) released additional follow-up results from the Phase ...

Vitamin D3 supplementation was associated with antihypertensive effects without significant between-dose differences among overweight older adults.

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

Firm elevates information strategy to enhance project delivery and efficiency Aaron White Appointed Chief Information & ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

A renewable natural gas plant operator at the Keystone Sanitary Landfill has the green light drill a nearly 3-mile-deep well ...